Prostate-Specific Antigen Control with Low-Dose Adjuvant Radiotherapy for High-Risk Prostate Cancer

Urology

Volumn 69, Issue 2, 2007, Pages 295-299

  Macdonald, O Kenneth ^a   Lee, R Jeffrey ^a   Snow, Greg ^b   Lee, Christopher M ^a   Tward, Jonathan D ^a   Middleton, Anthony W ^a   Middleton, George W ^a   Sause, William T ^a  

^a LDS HOSPITAL   (United States)

^b Statistical Data Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; DEATH; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GASTROINTESTINAL TOXICITY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHROTOXICITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RETROSPECTIVE STUDY; SEMINAL VESICLE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; URETHRA STRICTURE;

AGED; ANALYSIS OF VARIANCE; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33847069664     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.09.058     Document Type: Article

References (30)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Miller D.C., Hafez K.S., Stewart A., et al. Prostate carcinoma presentation, diagnosis, and staging: an update from the National Cancer Data Base. Cancer 98 (2003) 1169-1178
3. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial. J Clin Oncol 15 (1997) 1465-1469
4. Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591-1597
5. Anscher M.S., Robertson C.N., and Prosnitz R. Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update. Int J Radiat Oncol Biol Phys 33 (1995) 37-43
6. Lerner S.E., Blute M.L., Bergstralh E.J., et al. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J Urol 156 (1996) 137-143
7. Valicenti R.K., Gomella L.G., Ismail M., et al. Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma: effect of early adjuvant radiation therapy on biochemical control. Cancer 82 (1998) 1909-1914
8. Blute M.L., Bostwick D.G., Seay T.M., et al. Pathologic classification of prostate carcinoma: the impact of margin status. Cancer 82 (1998) 902-908
9. Eisbruch A., Perez C.A., Roessler E.H., et al. Adjuvant irradiation after prostatectomy for carcinoma of the prostate with positive surgical margins. Cancer 73 (1994) 384-388
10. Lee H.M., Solan M.J., Lupinacci P., et al. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Urology 64 (2004) 84-89
11. Leibovich B.C., Engen D.E., Patterson D.E., et al. Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol 163 (2000) 1178-1182
12. Meier R., Mark R., St Royal L., et al. Postoperative radiation therapy after radical prostatectomy for prostate carcinoma. Cancer 70 (1992) 1960-1966
13. Petrovich Z., Lieskovsky G., Langholz B., et al. Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys 53 (2002) 600-609
14. Petrovich Z., Lieskovsky G., Stein J.P., et al. Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer. BJU Int 89 (2002) 604-611
15. Vargas C., Kestin L.L., Weed D.W., et al. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Int J Radiat Oncol Biol Phys 61 (2005) 714-724
16. Bolla M., van Poppel H., Collette L., et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366 (2005) 572-578
17. Thompson I.M., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 296 (2006) 2329-2335
18. Wiegel T., Bottke D., Willich N., et al. Phase III results of adjuvant radiotherapy (RT) versus, wait and see (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP) (ARO 96-02/AUO AP 09/95). J Clin Oncol ASCO Proc 23 (2005) 4513
19. Valicenti R.K., Gomella L.G., Ismail M., et al. Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer. Int J Radiat Oncol Biol Phys 42 (1998) 501-506
20. Withers H.R., Peters L.J., and Taylor J.M. Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys 31 (1995) 353-359
21. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J 53 (1958) 457-481
22. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35 (1977) 1-39
23. Cox D.R. Regression models and life tables. J R Stat Soc B 34 (1972) 187-220
24. Graefen M., Karakiewicz P.I., Cagiannos I., et al. Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol 20 (2002) 951-956
25. Kattan M.W., Wheeler T.M., and Scardino P.T. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17 (1999) 1499-1507
26. Valicenti R.K., Gomella L.G., and Perez C.A. Radiation therapy after radical prostatectomy: a review of the issues and options. Semin Radiat Oncol 13 (2003) 130-140
27. Crane C.H., Rich T.A., Read P.W., et al. Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation. Int J Radiat Oncol Biol Phys 39 (1997) 681-686
28. Pisansky T.M., Kozelsky T.F., Myers R.P., et al. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol 163 (2000) 845-850
29. Song D.Y., Thompson T.L., Ramakrishnan V., et al. Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. Urology 60 (2002) 281-287
30. Lee C.M., Lee R.J., Handrahan D.L., et al. Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: analysis of clinical and dosimetric factors. Urology 65 (2005) 114-119